MR编号 | SE/H/1804/003 | ||||||
---|---|---|---|---|---|---|---|
药品名称 | Amlodipine/Valsartan/HCT +pharma | ||||||
活性成分 |
| ||||||
剂型 | Film-coated tablet | ||||||
上市许可持有人 | +pharma arzneimittel gmbh Austria | ||||||
参考成员国 - 产品名称 | Sweden (SE) | ||||||
互认成员国 - 产品名称 | |||||||
许可日期 | 2018/05/25 | ||||||
最近更新日期 | 2018/09/12 | ||||||
药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn(注:已撤市) | 撤市原因:2.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided could allow to conclude on a positive benefit-risk balance if the points for clarification identified were solved. |